Secondly, we the measured the expression of EDN3 after 5-Azacytidine (5-Aza), a DNMT1 inhibitor, treatment in cervical cancer cell lines to investigate the effect of methylation on EDN3 expression. This evidence concerns the gene EDN3 and cervical cancer.